Adalimumab Earns FDA Approval for Ulcerative Colitis in Children Adalimumab Earns FDA Approval for Ulcerative Colitis in Children

Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older with moderately to severely active ulcerative colitis.FDA Approvals
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Pediatrics News Alert Source Type: news